Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen - Van Cutsem, E; Tabernero, J; Lakomy, R (J Clin Oncol, 2012)
et al.